Comments on: ‘Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease – a randomized controlled trial’

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|25|1|e4-e4

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.25, Iss.1, 2018-01, pp. : e4-e4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease – reply

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 2, 2018-02 ,pp. : e27-e28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Droxidopa for the Short‐Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 5, 2015-04 ,pp. : 646-654

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin D deficiency in Parkinson's disease patients with orthostatic hypotension

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 4, 2015-10 ,pp. : 242-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Economic evaluation of occupational therapy in Parkinson's disease: A randomized controlled trial

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 8, 2015-07 ,pp. : 1059-1067

John Wiley & Sons Inc

Access to resources Recommend Favorite

In‐patient multidisciplinary rehabilitation for Parkinson's disease: A randomized controlled trial

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 8, 2015-07 ,pp. : 1050-1058

John Wiley & Sons Inc

Access to resources Recommend Favorite